Geofrey de Visscher
Corporate Officer/Principal at Katholieke Universiteit Leuven
Profile
Geofrey de Visscher is the founder of Anethon NV, which was founded in 2011.
He held the title of Inventor from 2011 to 2013.
Dr. de Visscher's current job is as a Principal at Katholieke Universiteit Leuven, which he started in 2001.
Dr. de Visscher's former job was as a Manager-Research & Innovation at the University of Antwerp, which he held from 2009 to 2011.
Dr. de Visscher received a doctorate degree from Maastricht University in 2001 and a graduate degree from Vrije Universiteit Brussel in 1997.
Geofrey de Visscher active positions
Companies | Position | Start |
---|---|---|
Katholieke Universiteit Leuven | Corporate Officer/Principal | 2000-12-31 |
Former positions of Geofrey de Visscher
Companies | Position | End |
---|---|---|
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Founder | 2013-08-06 |
University of Antwerp | Corporate Officer/Principal | 2011-09-30 |
Training of Geofrey de Visscher
Maastricht University | Doctorate Degree |
Vrije Universiteit Brussel | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |
- Stock Market
- Insiders
- Geofrey de Visscher